Genpact Limited

NYSE:G Lagerbericht

Marktkapitalisierung: US$5.5b

Genpact Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Genpact wird ein jährliches Gewinn- und Umsatzwachstum von 9.1% bzw. 7.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 10.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 22.5% betragen.

Wichtige Informationen

9.1%

Wachstumsrate der Gewinne

10.36%

EPS-Wachstumsrate

Professional Services Gewinnwachstum15.4%
Wachstumsrate der Einnahmen7.2%
Zukünftige Eigenkapitalrendite22.51%
Analystenabdeckung

Good

Zuletzt aktualisiert11 May 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Analyseartikel • Nov 12

Genpact Limited Just Beat EPS By 8.0%: Here's What Analysts Think Will Happen Next

Genpact Limited ( NYSE:G ) investors will be delighted, with the company turning in some strong numbers with its latest...

Recent updates

Seeking Alpha • May 10

Genpact: Q1 Results Confirm Stable Growth Trends

Summary Genpact Limited delivered a strong Q1, beating consensus on all key metrics and demonstrating robust growth in its AI-driven Advanced Technology Solutions (ATS) segment. G trades at a steep discount to peers—over 50% on multiples—despite high margins, accelerating AI adoption, and consistent free cash flow generation. Management guides for stable Q2 and FY2026, with ATS revenue expected to grow 20%+ and total revenue/EPS growth aligning closely with consensus forecasts. I maintain a Buy rating with a $43 target (32% upside), citing underappreciated AI transition, resilient financials, and disciplined capital returns. Read the full article on Seeking Alpha
Analyse-Update • May 08

G: AI Web Partnership And Ongoing Buybacks Will Support Future Shareholder Value

Analysts have slightly reduced their price target for Genpact to about $47.73 from roughly $48.18, reflecting small tweaks to fair value, discount rate, profit margin, and assumed future P/E that leave the overall valuation framework broadly intact. What's in the News Genpact and Parallel Web Systems announced a partnership that uses Parallel's AI native web agents and web search tools, delivered via API, to support information search, retrieval, and web intelligence across Genpact's business operations (Key Developments).
Neue Analyse • May 07

Agentic AI And Non FTE Models Will Shape Balanced Long Term Outcomes

Catalysts About Genpact Genpact provides business process and technology services, with a focus on data, AI and agentic solutions that help large enterprises run core operations. What are the underlying business or industry changes driving this perspective?
Analyse-Update • Apr 23

G: AI Partnership And Expanded Capital Returns Will Support Future Shareholder Value

Analysts have trimmed their price target on Genpact slightly to about $48.18 from roughly $48.64, reflecting updated assumptions around discount rate, revenue growth, profit margin and future P/E that remain largely in line with prior views. What's in the News Genpact announced a partnership with Parallel Web Systems to use Parallel's AI native web agents and search tools, delivered via APIs, to support information search, retrieval, and web intelligence across its business operations, including use cases in insurance and sales.
Analyse-Update • Apr 09

G: AI Partnership And Capital Returns Will Support Stronger Future Shareholder Value

Analysts kept their fair value estimate for Genpact steady at about $48.64, citing only small model tweaks in the discount rate, revenue growth, profit margin, and future P/E assumptions that did not materially alter their price target view. What's in the News Genpact entered a partnership with Parallel Web Systems to use Parallel's AI native web agents and web search tools via API, aiming to improve information search, retrieval, and web intelligence across business operations, including insurance claims and sales use cases (Key Developments).
Analyse-Update • Mar 25

G: Buybacks And Higher Dividend Will Drive Stronger Future Shareholder Returns

Analysts now hold Genpact's fair value steady at $48.64, with only small tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E used to support their unchanged price target view. What's in the News From October 1, 2025 to February 25, 2026, Genpact repurchased 3,415,026 shares, representing 1.98% of its share count, for $145.95m under its ongoing buyback program.
Analyse-Update • Mar 11

G: Buybacks And Higher Dividend Will Support Attractive Future Shareholder Returns

Analysts have maintained their $48.64 price target on Genpact. They have made small adjustments to assumptions such as the discount rate, revenue growth, profit margin, and future P/E ratio, which refine rather than change their overall view.
Analyse-Update • Feb 25

G: Buybacks And Higher Dividend Will Support Attractive Long Term Returns

Analysts have trimmed their price target for Genpact by a small amount to $48.64 from $48.82, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E estimates. What's in the News Genpact issued earnings guidance for the first quarter of 2026, with net revenues projected between US$1.282b and US$1.294b and diluted EPS in the US$0.79 to US$0.80 range (company guidance).
Analyseartikel • Feb 09

Genpact (NYSE:G) Is Increasing Its Dividend To $0.1875

Genpact Limited's ( NYSE:G ) dividend will be increasing from last year's payment of the same period to $0.1875 on 31st...
Analyse-Update • Feb 07

G: Buybacks And Rising Dividends Will Support Steady Long Term Outcomes

Analysts have trimmed their price target for Genpact from about US$50.91 to roughly US$48.82, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E levels. What's in the News Genpact reported that from October 1, 2025 to December 31, 2025, it repurchased 2,080,761 shares, representing 1.21% of shares, for US$100.06m under its ongoing buyback program.
Analyse-Update • Jan 10

G: AI Services And Buybacks Will Support Steady Long Term Outcomes

Analysts have nudged their price target on Genpact higher to about US$50.91 from roughly US$50.36, citing updated assumptions around revenue growth, profit margins, and future P/E levels. What's in the News Genpact updated full year 2025 guidance, now expecting net revenues of US$5.059b to US$5.071b, which the company describes as approximately 6.1% to 6.4% year over year as reported and 5.9% to 6.2% on a constant currency basis, compared with prior guidance of approximately 4.0% to 6.0% as reported (company guidance).
Analyse-Update • Dec 25

G: AI Services And Buybacks Will Support Balanced Long Term Performance

Analysts have nudged their price target for Genpact slightly higher to approximately 50.36 dollars from about 50.20 dollars, citing modestly improved long term growth and valuation assumptions, despite a small downward revision to profit margin forecasts. What's in the News Genpact reported that between July 1 and September 30, 2025, it repurchased 2,021,229 shares for about 89.99 million dollars, bringing total buybacks under its long running program to 68,817,622 shares, or 35.4 percent of shares outstanding, for roughly 2.29 billion dollars (company buyback update).
Analyse-Update • Dec 11

G: AI Insurance Workflow Suite And Buybacks Will Support Steady Future Performance

Analysts have modestly raised their price target on Genpact to $50.20, citing slight improvements in discount rate assumptions and forward valuation metrics while maintaining a stable fair value outlook. What's in the News Completed a major share repurchase tranche, buying back 2,021,229 shares in the latest quarter and reaching a cumulative 35.4% of shares repurchased under the multi year program announced in 2015 (company filing) Raised full year 2025 revenue guidance to $5.059 billion to $5.071 billion, implying 6.1% to 6.4% year over year growth as reported, with stronger outlooks for both Data Tech AI and Digital Operations segments (company guidance) Guided fourth quarter 2025 revenues to $1.298 billion to $1.311 billion, targeting 4.0% to 5.0% reported growth and diluted EPS of $0.78 to $0.80 (company guidance) Launched the Genpact Insurance Policy Suite for commercial and specialty insurance, an AI driven workflow offering built on Microsoft Azure and aimed at achieving up to 90% touchless submission clearance and significantly lower operating costs for insurers (product announcement) Valuation Changes Fair Value Estimate is unchanged at $50.20 per share, reflecting a stable fundamental outlook.
Analyse-Update • Nov 26

G: AI Will Drive Efficiency With Lower Costs In Insurance Workflows

Analysts have slightly lowered their price target for Genpact from $50.30 to $50.20. They cited modestly improved revenue growth and profit margin forecasts, balanced by a decrease in future price-to-earnings expectations.
Analyseartikel • Nov 12

Genpact Limited Just Beat EPS By 8.0%: Here's What Analysts Think Will Happen Next

Genpact Limited ( NYSE:G ) investors will be delighted, with the company turning in some strong numbers with its latest...
Analyse-Update • Nov 07

G: Insurance AI Workflows Will Drive Efficiency and Cost Reduction

Analysts have maintained Genpact's fair value estimate at $50.30. They cite steady expectations for future growth and margins, despite a slight uptick in the discount rate and projected price-to-earnings ratio.
Analyse-Update • Oct 24

AI Solutions And Buybacks Will Shape Future Service Transformation

Analysts have lowered their price target for Genpact from $52.44 to $50.30, citing modest reductions in projected revenue growth and profit margin expectations. What's in the News Genpact launched the Genpact Insurance Policy Suite, an AI-powered workflow solution for commercial and specialty insurance.
Analyseartikel • Aug 06

Is It Time To Consider Buying Genpact Limited (NYSE:G)?

NYSE:G 1 Year Share Price vs Fair Value Explore Genpact's Fair Values from the Community and select yours Genpact...
Analyseartikel • Jul 16

Benign Growth For Genpact Limited (NYSE:G) Underpins Its Share Price

With a price-to-earnings (or "P/E") ratio of 14.6x Genpact Limited ( NYSE:G ) may be sending bullish signals at the...
Analyseartikel • Jul 03

Is Genpact (NYSE:G) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel • Jun 19

Is There An Opportunity With Genpact Limited's (NYSE:G) 44% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Genpact fair value estimate is US$75.14 Current share price of...
Seeking Alpha • Feb 23

Genpact: AI Explosion Exposure, But Not That Cheap Anymore (Rating Downgrade)

Summary Genpact's diverse client base and exposure to high-growth markets like AI and digital transformation have driven significant revenue and free cash flow growth. The company's proprietary AI platform, Genpact Cora, enhances customer experience and accelerates digital transformation, contributing to its solid financial performance. Recent dividend increases and a $500 million stock repurchase program indicate strong shareholder returns, potentially boosting future stock demand. Despite positive financials, the stock's current valuation limits upside potential, leading me to close my position due to decreased margin of safety. Read the full article on Seeking Alpha
Seeking Alpha • Jan 05

Genpact Limited: The Overlooked Value Stock In Digital Transformation

Summary Genpact Limited (G) is a value investment with strong fundamentals, including consistent revenue growth, stable margins, and a conservative balance sheet. G's leadership in digital transformation and business process outsourcing, along with a diverse client base, supports its long-term investment potential. Macro factors like global economic conditions, inflation, and currency exchange rates can impact G's performance, but its operational efficiencies and recurring revenue model provide stability. G's intrinsic valuation suggests significant upside, with a target price of ~$61 per share, making it a compelling buy-and-hold opportunity. Read the full article on Seeking Alpha
Seeking Alpha • Dec 16

Genpact: Steady Performer But Wait For A Wider Margin Of Safety

Summary Genpact's stock appreciated 25.83% since February 2024, outperforming the S&P 500, but the current price offers only a 5.41% margin of safety. Under new CEO Balkrishan Kalra, Genpact's 3+1 Execution Framework has driven significant revenue and earnings growth, particularly through Data-Tech-AI initiatives. The company raised its revenue and earnings guidance three times in 2024, reflecting strong performance and increased client engagement through strategic partnerships. Despite an improved fair value of $47.09, the current price of $44.67 suggests holding shares rather than buying due to a smaller margin of safety. Read the full article on Seeking Alpha

Gewinn- und Umsatzwachstumsprognosen

NYSE:G - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20286,325737N/A7145
12/31/20275,83566579481012
12/31/20265,43661070872512
3/31/20265,161570651749N/A
12/31/20255,080552724813N/A
9/30/20255,009551642729N/A
6/30/20254,929538562650N/A
3/31/20254,851528598681N/A
12/31/20244,767514530615N/A
9/30/20244,665663520604N/A
6/30/20244,589648460537N/A
3/31/20244,519642429499N/A
12/31/20234,477631432491N/A
9/30/20234,433430473529N/A
6/30/20234,408408542593N/A
3/31/20234,392363474524N/A
12/31/20224,371353389444N/A
9/30/20224,341337401461N/A
6/30/20224,246343381445N/A
3/31/20224,145374442503N/A
12/31/20214,022369637694N/A
9/30/20213,901371547607N/A
6/30/20213,820354585649N/A
3/31/20213,732314610680N/A
12/31/20203,709308504584N/A
9/30/20203,700315428512N/A
6/30/20203,653318378480N/A
3/31/20203,635330304415N/A
12/31/20193,521305N/A428N/A
9/30/20193,415302N/A478N/A
6/30/20193,274287N/A411N/A
3/31/20193,121278N/A361N/A
12/31/20183,001282N/A340N/A
9/30/20182,900270N/A298N/A
6/30/20182,861270N/A293N/A
3/31/20182,803274N/A301N/A
12/31/20172,737263N/A359N/A
9/30/20172,684272N/A373N/A
6/30/20172,624268N/A375N/A
3/31/20172,584264N/A386N/A
12/31/20162,571270N/A346N/A
9/30/20162,536258N/A310N/A
6/30/20162,505257N/A299N/A
3/31/20162,484254N/A294N/A
12/31/20152,461240N/A327N/A
9/30/20152,416221N/A347N/A
6/30/20152,386200N/A293N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: GDas prognostizierte Gewinnwachstum (9.1% pro Jahr) liegt über der Sparquote (3.5%).

Ertrag vs. Markt: GDie Erträge des Unternehmens (9.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (16.7% pro Jahr).

Hohe Wachstumserträge: GDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: GDie Einnahmen des Unternehmens (7.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.6% pro Jahr).

Hohe Wachstumseinnahmen: GDie Einnahmen des Unternehmens (7.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: GDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (22.5%)

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/11 02:17
Aktienkurs zum Tagesende2026/05/11 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Genpact Limited wird von 23 Analysten beobachtet. 12 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
David KoningBaird
Keith BachmanBMO Capital Markets Equity Research
Kunal TayalBofA Global Research